IPSC vs SRPT · rev $6.6M vs rev $1.90B
Century Therapeutics Inc (IPSC) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
IPSC currently screens at market cap $47.8M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the IPSC and SRPT stock pages for the full models.
Not investment advice.